Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage ; volume:6 ; number:1 ; day:8 ; month:1 ; year:2021 ; pages:1-10 ; date:12.2021
npj vaccines ; 6, Heft 1 (8.1.2021), 1-10, 12.2021
- Urheber
-
Dubois, Violaine
Chatagnon, Jonathan
Thiriard, Anaïs
Bauderlique-Le Roy, Hélène
Debrie, Anne-Sophie
Coutte, Loïc
Locht, Camille
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-020-00270-8
- URN
-
urn:nbn:de:101:1-2021020601212207226040
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dubois, Violaine
- Chatagnon, Jonathan
- Thiriard, Anaïs
- Bauderlique-Le Roy, Hélène
- Debrie, Anne-Sophie
- Coutte, Loïc
- Locht, Camille
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Fluoreszenzmikroskopische Untersuchungen auf Bordetella pertussis
Extraction of the outer membrane protein pertactin from Bordetella pertussis with urea for the production of acellular pertussis vaccine
Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
Fim3-dependent autoagglutination of Bordetella pertussis
Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
Charakterisierung des Hfq-Regulons in Bordetella pertussis und Bordetella bronchiseptica
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Fluoreszenzmikroskopische Untersuchungen auf Bordetella pertussis
Extraction of the outer membrane protein pertactin from Bordetella pertussis with urea for the production of acellular pertussis vaccine
Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
Fim3-dependent autoagglutination of Bordetella pertussis
Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
Charakterisierung des Hfq-Regulons in Bordetella pertussis und Bordetella bronchiseptica
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Proteomics of Bordetella pertussis whole-cell and acellular vaccines
Fluoreszenzmikroskopische Untersuchungen auf Bordetella pertussis
Extraction of the outer membrane protein pertactin from Bordetella pertussis with urea for the production of acellular pertussis vaccine
Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
Fim3-dependent autoagglutination of Bordetella pertussis
Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model
Charakterisierung des Hfq-Regulons in Bordetella pertussis und Bordetella bronchiseptica
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003